Anti-Cytokeratin 10, clone SPM261

Anti-Cytokeratin 10, clone SPM261
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
NSJ-V9057-20UG 20 µg - -

3 - 10 Werktage*

375,00 €
NSJ-V9057-100UG 100 µg - -

3 - 10 Werktage*

810,00 €
 
0.2 mg/ml with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide. CK10 is expressed in all... mehr
Produktinformationen "Anti-Cytokeratin 10, clone SPM261"
0.2 mg/ml with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide. CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation, it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts.
Schlagworte: Anti-KPP, Anti-K10, Anti-KRT10, Anti-CK-10, Anti-Keratin-10, Anti-Cytokeratin-10, Anti-Keratin, type I cytoskeletal 10, Cytokeratin 10 Antibody
Hersteller: NSJ Bioreagents
Hersteller-Nr: V9057

Eigenschaften

Anwendung: FC, IF, IHC
Antikörper-Typ: Monoclonal
Klon: SPM261
Konjugat: No
Wirt: Mouse
Spezies-Reaktivität: human, mouse
Immunogen: Skin extract of a human Psoriasis patient were used as the immunogen for this Cytokeratin 10 antibody.
Format: Purified

Handhabung & Sicherheit

Lagerung: +4°C
Versand: +4°C (International: +4°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-Cytokeratin 10, clone SPM261"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen